... GlaxoSmithKline plc, Novartis AG and Teva Pharmaceutical Industries Ltd. Other prominent vendors in this market are: Abbvie Inc., Akorn Inc., Astellas Pharma Inc., Desitin Arzneimittel GmbH, Endo International plc, F. Hoffmann-La Roche Ltd., H. Lundbeck ...  |  read more...

... Bayer AG , Eli Lilly and Co., Merck & Co., Pfizer Inc. , AbbVie Inc., Adamis Pharmaceuticals Corp., Agile Therapeutics Inc., Amgen Inc., ANI Pharmaceuticals Inc., ApothecusPharmaceutical Corp., AstraZeneca plc, Blairex Laboratories Inc., Catalysis SL, ...  |  read more...

... Pfizer Inc., Astellas Pharma Inc., Abbvie Inc., Repros Therapeutics Inc., Sanofi SA, Takeda Pharmaceuticals Co. Ltd. Commenting on the report, an analyst from TechNavio’s team said: “The launch of high-cost GnRH antagonist therapies such as ...  |  read more...

... need for curative therapy in the absence of a preventative vaccine. A treatment revolution is underway as the market moves away from protease inhibitors and interferon regimens and toward highly-effective, easily tolerated interferon-free oral therapies, ...  |  read more...

... AG, F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron Pharmaceuticals Inc., Acucela Inc., Advanced Cell Technology Inc., Alexion Pharmaceuticals Inc., Alimera Sciences Inc., Allergen Inc., Allergo Opthalmics LLC, Avalanche Biotechnologies Inc., Gilead Sciences Inc., GlaxoSmithKline plc, ...  |  read more...

... Visiongain’s brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there. Our 217-page report provides 132 tables, charts, and graphs. Discover the most lucrative areas in the industry and ...  |  read more...

... damage to the neuronal myelin sheath, which slows down nerve conduction velocity. Axonal damage associated with diabetic neuropathy decreases nerve action potential below normal physiological level, which inhibits neuronal signal transmission. About 60 to 70 ...  |  read more...

... This report provides: An overview of the global market for systemic antibiotics. Analyses of global market trends, with data from 2013, and projections of compound annual growth rates (CAGRs) through 2018. Details on the factors ...  |  read more...

... rapidly gaining widespread acceptance as a drug discovery and life science research tool. Currently, the drug discovery process is based on target identification and screening for drug candidates. The label-free technologies are used for studying ...  |  read more...

... Lifestyle habits such as diet, exercising, and smoking are the major causes of hypertension. Hypertension can damage organs and lead to several illnesses such as renal failure, aneurysm, heart failure, stroke, and heart attack. There ...  |  read more...

... this market growth is the increasing global aging population. The Global Pain Management Drugs market has also been witnessing intense competition among vendors. However, the increase in generic competition could pose a challenge to the ...  |  read more...

... predictions, also exploring research and development. Those treatments hold high potentials. There you assess results, progress, therapies, and opportunities. Knowledge facilitates success. Visiongain's new report forecasts those revenues to 2024 at overall world market, submarket, ...  |  read more...